Low-profile Shanghai-based CDMO secures high profile investors for 9-digit Series C – Endpoints News
In a bid to expand R&D and manufacturing capabilities, Shanghai-based ZhenGe Biotech webted a $100 million Series C Tuesday. With ...
Tag: Shanghaibased
POPULAR NEWS
